Microdosing

Microdosing refers to the practice of taking very small, sub-perceptual doses of a psychedelic substance—typically about 1/10th to 1/20th of a recreational dose—on a regular schedule. With psilocybin mushrooms, this usually means 0.1-0.3 grams of dried mushrooms taken every few days. The goal is not to "trip" but to experience subtle enhancements to mood, creativity, focus, and overall well-being.

What is a Microdose?

A microdose is defined as a dose small enough that it doesn't produce noticeable psychedelic effects. You shouldn't feel "high" or experience visual distortions. Instead, effects are subtle—often described as feeling like "a really good day" rather than an altered state. If you're noticing significant effects, the dose is too high.

Typical microdose ranges for Psilocybe cubensis: • Threshold: 0.05-0.1g (very subtle, good for sensitive individuals) • Light: 0.1-0.2g (most common starting point) • Standard: 0.2-0.3g (may be noticeable for some)

Note that potency varies significantly between strains. A microdose of Penis Envy might be half that of Golden Teacher.

Common Protocols

Several microdosing schedules have become popular:

• Fadiman Protocol: One day on, two days off. Take a microdose on Day 1, then take Days 2 and 3 off. Repeat. This is the most researched protocol.

• Stamets Stack: Four days on, three days off. Often combined with lion's mane mushroom and niacin, which Paul Stamets believes enhances neurogenesis.

• Intuitive: Microdose when you feel called to, without a fixed schedule. Some prefer this more flexible approach.

Most practitioners recommend taking breaks after 4-8 weeks to prevent tolerance and assess baseline changes.

Reported Benefits

While research is still limited, microdosers commonly report:

• Enhanced creativity and problem-solving
• Improved mood and reduced anxiety
• Increased focus and productivity
• Greater emotional awareness and openness
• Enhanced appreciation for nature and art
• Reduced symptoms of depression (anecdotal)

It's important to note that placebo effects may account for some reported benefits, and individual responses vary widely.

Potential Risks and Considerations

• Legal status: Psilocybin remains illegal in most jurisdictions, even in small amounts.
• Cardiac concerns: Some research suggests frequent 5-HT2B receptor activation could theoretically affect heart valves, though this hasn't been demonstrated with typical microdosing.
• Mental health: Those with psychotic disorders or family history should avoid microdosing.
• Drug interactions: Psilocybin can interact with SSRIs, lithium, and other medications.
• Tolerance: Effects may diminish over time, requiring breaks.